{"id":"NCT04674189","sponsor":"CureVac","briefTitle":"A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19","officialTitle":"COVID-19: A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Clinical Study Evaluating the Safety and Immunogenicity of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adult Health Care Workers in Mainz (Germany)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-12-23","primaryCompletion":"2022-06-08","completion":"2022-06-08","firstPosted":"2020-12-19","resultsPosted":"2023-10-06","lastUpdate":"2023-10-06"},"enrollment":2357,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Coronavirus","Covid19","SARS-CoV-2","Severe Acute Respiratory Syndrome"],"interventions":[{"type":"BIOLOGICAL","name":"CVnCoV Vaccine","otherNames":["CV07050101"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"CVnCoV: Group 1, Lot 1","type":"EXPERIMENTAL"},{"label":"CVnCoV: Group 2, Lot 2","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study aims to evaluate the safety (in all participants) and reactogenicity (in a subset of participants) of CVnCoV administered as a 2-dose schedule to adult participants 18 years of age or older. The study also aims to assess antibody responses to the receptor-binding domain (RBD) of spike (S) protein of SARS-CoV-2 after 1 and 2 doses of CVnCoV in adults 18 years of age or older included in a subset of participants.","primaryOutcome":{"measure":"Number of Participants Who Experienced a Medically Attended Adverse Event (AE) Occurring in the Following 6 Months After Dose 2","timeFrame":"Up to 6 months after Dose 2 (Days 29 to 211)","effectByArm":[{"arm":"CVnCoV: Group 1, Lot 1","deltaMin":95,"sd":null},{"arm":"CVnCoV: Group 2, Lot 2","deltaMin":133,"sd":null},{"arm":"Placebo","deltaMin":58,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":7,"exclusionCount":15},"locations":{"siteCount":1,"countries":["Germany"]},"refs":{"pmids":["39040887"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":783},"commonTop":["Headache","Fatigue","Injection site pain","Myalgia","Chills"]}}